In one paragraphArticle in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
A-Hyeon LeeCenter for Nucleic Acid Therapies at the Department of Chemistry Institute for Chemical Epigenetics, Ludwig-Maximilians-Universität München, Butenandtstr. 5-13, 81377 München, Germany.ORCID 0000-0002-5422-6107 Seung Min LeeHanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul 04763, Republic of Korea.ORCID 0000-0001-9635-2921 In Young KangDepartment of Translational Medicine, Graduate School of Biomedical Science & Engineering, Hanyang University, Seoul 04763, Republic of Korea.
Gye Ryeol ParkDepartment of Translational Medicine, Graduate School of Biomedical Science & Engineering, Hanyang University, Seoul 04763, Republic of Korea.
Hye Hyun YooPharmacomicrobiomics Research Center and College of Pharmacy, Hanyang University,Ansan 15588, Republic of Korea.ORCID 0000-0001-8282-852X Jun Sang YuInstitute of Pharmaceutical Science and Technology and College of Pharmacy, Hanyang University, Ansan 15588, Republic of Korea.ORCID 0000-0002-5720-5934 Hyun Sung KimDepartment of Pathology, Hanyang University College of Medicine, Seoul 04763, Republic of Korea.ORCID 0000-0002-8935-7414 Ji-Hee ShinResearch Group of Personalized Diet, Korea Food Research Institute, Wanju-gun 55365, Republic of Korea.ORCID 0000-0001-9224-5125 Young-Do NamResearch Group of Personalized Diet, Korea Food Research Institute, Wanju-gun 55365, Republic of Korea.
Eileen Laurel YoonDepartment of Translational Medicine, Graduate School of Biomedical Science & Engineering, Hanyang University, Seoul 04763, Republic of Korea.
Dae Won JunDepartment of Translational Medicine, Graduate School of Biomedical Science & Engineering, Hanyang University, Seoul 04763, Republic of Korea.ORCID 0000-0002-2875-6139 Funding
Hanyang University HY-202300000003034Seoul ANCHOR Center 2026-ANCHOR-01-027-01
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Chenodeoxycholic AcidNon-alcoholic Fatty Liver DiseaseAnimalsBile Acids and SaltsDisease Models, AnimalGastrointestinal MicrobiomeLiverMaleMiceMice, Inbred C57BLBile Acids and SaltsChenodeoxycholic Acidobeticholic acidbile acids (BAs)metabolic dysfunction-associated steatotic liver disease (MASLD)microbiomeobeticholic acid (OCA)pharmacokinetics (PK)
Identifiers
PMID42884747
PMCPMC13667209
What OpenQuestion holds
Textmetadata
Read underepoch 390